Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?

Dean A. Seehusen, Nicolas Rathjen

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	E15
Journal	Evidence-Based Practice
Volume	20
Issue number	12
State	Published - Dec 2017
Externally published	Yes

ASJC Scopus subject areas

Fundamentals and skills

Other files and links

Cite this

@article{567532b826a146609617d6fe15965e65,

title = "Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?",

author = "Seehusen, {Dean A.} and Nicolas Rathjen",

year = "2017",

month = dec,

language = "English (US)",

volume = "20",

pages = "E15",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Dowden Health Media,Inc",

number = "12",

}

TY - JOUR

T1 - Dabigatran or rivaroxaban for nonvalvular atrial fibrillation?

AU - Seehusen, Dean A.

AU - Rathjen, Nicolas

PY - 2017/12

Y1 - 2017/12

UR - http://www.scopus.com/inward/record.url?scp=85050765213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050765213&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:85050765213

SN - 1095-4120

VL - 20

SP - E15

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 12

ER -